drugset / Trial / NCT00508911

A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills

NCT00508911

Phase 1 Terminated 4 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study will be conducted in healthy female volunteers to investigate the effect of GW876008 on the pharmacokinetics of oral contraceptive pills.

Timeline

Start
2007-06-08
Primary completion
2007-10-22
Completion
2007-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule 125 mg Oral
Subject Levonorgestrel Small molecule 150 ug Oral
Subject ethinyl estradiol Small molecule 30 ug Oral

Indications